KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Other Non-Current Assets (2018 - 2025)

Vir Biotechnology's Other Non-Current Assets history spans 8 years, with the latest figure at $7.0 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 9.43% to $7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.0 million, a 9.43% increase, with the full-year FY2025 number at $7.0 million, up 9.43% from a year prior.
  • Other Non-Current Assets hit $7.0 million in Q4 2025 for Vir Biotechnology, roughly flat from $7.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for VIR hit a ceiling of $94.4 million in Q1 2025 and a floor of $6.4 million in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $11.4 million across 5 years, with a median of $7.0 million in 2025.
  • Biggest five-year swings in Other Non-Current Assets: decreased 25.45% in 2023 and later skyrocketed 1368.57% in 2025.
  • Tracing VIR's Other Non-Current Assets over 5 years: stood at $7.0 million in 2021, then dropped by 5.0% to $6.7 million in 2022, then decreased by 3.12% to $6.4 million in 2023, then dropped by 1.32% to $6.4 million in 2024, then increased by 9.43% to $7.0 million in 2025.
  • Business Quant data shows Other Non-Current Assets for VIR at $7.0 million in Q4 2025, $7.0 million in Q3 2025, and $7.0 million in Q2 2025.